approval · primary record
TRIAMCINOLONE ACETONIDE
3 approval events · latest 2025-05-22
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Latest action | 2025-05-22 |
| Approval events | 3 |
| Brand | XIPERE |
| Sponsor | BAUSCH AND LOMB INC |
| Route | INJECTION |
Approval history
3 actions on record. The drug is the stable record; each action below is an event with its own date, so this URL keeps working as new actions arrive.
| Date | Agency | Type | Brand | Sponsor | Route |
|---|---|---|---|---|---|
| 2025-05-22 | FDA | NDA | XIPERE | BAUSCH AND LOMB INC | INJECTION |
| 2025-05-09 | FDA | NDA | NASACORT ALLERGY 24 HOUR | CHATTEM SANOFI | NASAL |
| 2024-12-03 | FDA | NDA | ZILRETTA | PACIRA PHARMS INC | INTRA-ARTICULAR |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-30T00:30:47.293Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: approval:triamcinolone-acetonide
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.
Same entity, elsewhere in the suite
- Triamcinolone Acetonide · compound